Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J WHANG

Showing results (161-170 of 214) with videos related to

Pageof 22
Sort By:
Science (New York, N.Y.)|January 8, 1982
Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23)J Whang-Peng, C S Kao-Shan, E C Lee, et al.
Cancer|February 15, 1996
Phase II study of flutamide in the treatment of hepatocellular carcinomaY Chao, W K Chan, Y S Huang, et al.
The Journal of Biological Chemistry|October 15, 1988
Structure of the human neutrophil elastase geneH Takahashi, T Nukiwa, K Yoshimura, et al.
Cancer Research|April 15, 1997
Identification of mutations at DNA topoisomerase I responsible for camptothecin resistanceL F Wang, C Y Ting, C K Lo, et al.
Cancer Letters|December 20, 1996
Protein tyrosine phosphatase activities are involved in apoptotic cancer cell death induced by GL331, a new homolog of etoposideT S Huang, C H Shu, Y L Shih, et al.
Anticancer Research|March 4, 2000
The significance of body weight change in non-Hodgkins lymphomaY H Chin, J M Liu, J J Tai, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed|September 2, 2000
Combination chemotherapy with tamoxifen, ifosfamide, epirubicin and cisplatin in extensive-disease small-cell lung cancerY M Chen, R P Perng, K Y Yang, et al.
Oncogene|January 1, 1994
Examination of human tumors for rhoA mutationsJ A Moscow, R He, J R Gnarra, et al.
American Journal of Clinical Oncology|February 22, 2000
A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancerY M Chen, R P Perng, K Y Yang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 9, 2005
Stage migration influences on stage-specific survival comparison between D1 and D3 gastric cancer surgeriesC W Wu, C A Hsiung, S S Lo, et al.
Pageof 22

Showing results (161-170 of 214) with videos related to

Sort By:
Pageof 22
Science (New York, N.Y.)|January 8, 1982
Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23)J Whang-Peng, C S Kao-Shan, E C Lee, et al.
Cancer|February 15, 1996
Phase II study of flutamide in the treatment of hepatocellular carcinomaY Chao, W K Chan, Y S Huang, et al.
The Journal of Biological Chemistry|October 15, 1988
Structure of the human neutrophil elastase geneH Takahashi, T Nukiwa, K Yoshimura, et al.
Cancer Research|April 15, 1997
Identification of mutations at DNA topoisomerase I responsible for camptothecin resistanceL F Wang, C Y Ting, C K Lo, et al.
Cancer Letters|December 20, 1996
Protein tyrosine phosphatase activities are involved in apoptotic cancer cell death induced by GL331, a new homolog of etoposideT S Huang, C H Shu, Y L Shih, et al.
Anticancer Research|March 4, 2000
The significance of body weight change in non-Hodgkins lymphomaY H Chin, J M Liu, J J Tai, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed|September 2, 2000
Combination chemotherapy with tamoxifen, ifosfamide, epirubicin and cisplatin in extensive-disease small-cell lung cancerY M Chen, R P Perng, K Y Yang, et al.
Oncogene|January 1, 1994
Examination of human tumors for rhoA mutationsJ A Moscow, R He, J R Gnarra, et al.
American Journal of Clinical Oncology|February 22, 2000
A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancerY M Chen, R P Perng, K Y Yang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 9, 2005
Stage migration influences on stage-specific survival comparison between D1 and D3 gastric cancer surgeriesC W Wu, C A Hsiung, S S Lo, et al.
Pageof 22